Teradyne (TER) Revenue — Quarter Ended Oct 1, 2023
Revenue increased from the preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement partially offset the year-over-year shortfall.
Key takeaway
Quarter ended Oct 1, 2023 · FY2023 Q3
Revenue increased from the preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement partially offset the year-over-year shortfall.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$703.7M
Revenue reported for this quarter.
Quarter-over-quarter
+2.8%
Change from the immediately preceding quarter.
Year-over-year
-14.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $731.8M | -17.3% |
| Apr 2, 2023 | $617.5M | -18.2% |
| Jul 2, 2023 | $684.4M | -18.6% |
| Oct 1, 2023 | $703.7M | -14.9% |
Revenue performance
The reported revenue rose from the prior quarter, reflecting a reversal of the preceding period's downward trajectory. However, it remained below the level seen in the same quarter last year.
Quarterly comparison
Revenue increased sequentially, breaking a streak of declines from the prior two quarters. Compared to the same quarter a year ago, revenue was lower, consistent with the broader trailing annual trend.
What to watch
Monitor whether the sequential revenue growth can be sustained given the year-over-year decline and the prior quarters' decreases.